<div class="text-justify">

#### Poland is a very specific country, what is highlighted on every step by illogical political decisions by Polish Government. Too often we’re victims of political biases. We tilt to judge many things more by moral sense and so called “logic” than science. We’re taking too many things for granted. All of this leads to education problems. Exemplification of that attitude is data in which we can read the following: Poland is a country with lowest awareness about HIV infection among European countries. In addition, 50 -70% seropositive people do not know about infection (Ankiersztejn-Bartczak M., 2012)[1](http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.desklight-031a84da-c259-4587-a18d-8f444ea21fca/c/1_P_review.pdf). Outcome of that is higher probability of spread HIV infections among people. In public space we have a lot of myths about HIV and sexual activities. Additionally, the attempt to ignore HIV and persuade that it is only problem of specific social groups resulted in a pandemic that killed 35 million people[2](https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics).  

<center>
![](https://cdn.steemitimages.com/DQmYd8Hg8YKa4rq2PRwks8dtaLA6jDYLZ4UuxrawGziyNAe/image.png)
</center>

###### Figure [A](https://wellcomecollection.org/works/jgsmm3ud?query=HIV) – Probably, you cannot see it, but this is a nervous tissue and it is not completely healthy.  In the picture we can find a microglial which is changed after contact with HIV. This transformed microglial we call multinucleated cells. That kind of pictures is typical for encephalopathy caused by HIV. Microglia comes from mesoderm and its function is analogous to leukocytes. This is a very special population of cells in CNS because only microglia do not come from neuroepithelium. License: [CC0](https://creativecommons.org/publicdomain/zero/1.0/deed.pl)

### Transmission 
###
In heterosexual contacts, probability of being infected is greater among women. This is a result of **larger surface** of vaginal mucous membrane which can be in touch with infected ejaculate (Olczak A., Grąbczewska E., 2012)[3](https://s3.amazonaws.com/academia.edu.documents/40503941/Przeg_Epidem_1-2012.pdf?AWSAccessKeyId=AKIAIWOWYYGZ2Y53UL3A&Expires=1526237296&Signature=IIFweFDW3GNiduilE9eNiqssId8%3D&response-content-disposition=inline%3B%20filename%3DDETERM_INANT_Y_PRO_ZDRO_WOTN_EJ_AKTYWNO.pdf#page=83). The same dependence occurs in receptive anal sex, where mucous membrane is very well-developed. Additionally, semen component like **spermine** and **collagenase** damages the mucous membrane of rectum which facilitates the penetration of HIV. This is why both woman and man who chose an unprotected anal sex have greater risk of HIV infection compared to another sexual activities (Alemagno A. S., et al., 1998)[4](https://ajph.aphapublications.org/doi/pdf/10.2105/AJPH.88.8.1265-a). **Lowest risk of transmission HIV infection is when we decide on oral sex**. It results from specific histology of human throat where epithelium is much thicker what determines a better mechanical barrier for the virus. Throat have less lymphocytes CD4+ then rectum. Additionally, throat epithelium secretes a lot of different substance which can restrain HIV activity (Patel P., et al., 2014)[5](https://journals.lww.com/aidsonline/Fulltext/2014/06190/Estimating_per_act_HIV_transmission_risk___a.14.aspx). 
 
<center>
 ![HIV 2018.jpg](https://ipfs.busy.org/ipfs/QmSxJYXspCtNzYGatjA59c7nWFdAWRgXCdHvicQc6ngB3J)
</center>
###### Figure [B](http://wwwold.pzh.gov.pl/oldpage/epimeld/hiv_aids/index.htm) – In 2017 we detected 1526 of new case of HIV infection. License: [CC BY-SA 3.0](https://creativecommons.org/licenses/by/3.0/deed.en)


### Old fashioned prophylaxis 

First answer to the question “How can I avoid HIV infection?” that we think of, is “don’t have sex”. It’s a good time to ask ourselves one more question – why grown-up people have to back out of sexual activities to avoid infection? Fear of HIV should only prompt to looking for more safety and effective ways of securing ourselves during sexual intercourses.

##### Strategy of prophylaxis:
* Sexual education 
* Fidelity and abstinence 
* Use condoms 
* Use lubricants and microbicides
* Keep off risky sexual behaviors
#####
Statistics of HIV infections show us that the common methods of prophylaxis are not effective enough, because in many European region (including Poland) we can observe a lot of new HIV infections. Once again, education is a key to prevent spreading new HIV and STD infections but we must educate in well studied way e.g. it’s important to include a psychological and sexological aspects of human sexual drive.

<center>
![image.png](https://ipfs.busy.org/ipfs/QmZ6ZNz7Cwb8iajpnUHHWgbmnvMbRkTG3b9biNWk7d6oXo)
</center>  

###### Figure [C](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526984/figure/F1/) – in the slide we can see a lot of blood vessel. It’s brings me some kind of oncological disturbance (if there is more blood vessel it is easier to have metastasis). Additionally, if we see this pathology in macroscopic image then we should notice small red or blue freckle which can evolve to tubercle. This kind of image arise in case of immunodeficiency, where HHV-8 infection shows up as Kaposi sarcoma. License: [CC BY 2.0](https://creativecommons.org/licenses/by/2.0/)

### Pre-exposure prophylaxis (PrEP)

PrEP is method based on taking antiretroviral medicaments by noninfected person before exposure on HIV. PrEP is the answer to the still existing threat of HIV. This method is recommended by WHO as one of most effective way to preventing infection. 

In PrEP, person takes one tablet containing **tenofovir** (TDF) and **emtricitabine** (FTC) every single day, always on the same hour. The consequence of regular use of this medicament is decreased risk of getting a HIV by 86-95%. Of course, we should still use condom if we want to protect ourselves from other STD, PrEP cannot help us in this manner.

##### Medical indication for use of PrEP:
* Sexual contact with person who have an unknown serological status. 
* Sexual contact with seropositive person.
* Sexual contact with person who use intravenous drags. 
#####
We have two most common ways to administrate PrEP. First is based on taking one pill per day continuously as long as we are exposed on infection e.g. HIV-positive partner. Second way is based on taking two pills up to 2-24 hours before sexual contact and one pill after 24 hours and the last pill after 48 hours after the first dose. This second way is very important, especially when there’s a possibility that we will make anal sex as a recipient. This is because prophylactic TDF concentration in rectum occurs after one day. In opposite to vagina where it takes up to 3-7 days. Additionally, TDF concentration is 100 % bigger in rectum then in vagina (Boroń - Kaczmarska A., Wiercińska – Drapało A., 2017).  

There is one threat connected with PrEP. When HIV-positive person takes PrEP. It is dangerous because it can lead to drug resistance. Therefore, it is important to do tests for **anti-HIV** antibodies and **p-24** antigen and to exclude the early retroviral disease.


### It is possibility to use antiretroviral meds in case of postexposure prophylaxis. It is important to include medicaments up to 48 hours after exposure (Rymer W., et al., 2016)[6](http://www.ptnaids.pl/pliki/zalecenia_2016_uzupelnione.pdf#page=29).
___
##### References:
[1](http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.desklight-031a84da-c259-4587-a18d-8f444ea21fca/c/1_P_review.pdf)  Ankiersztejn-Bartczak M., 2012
[2](https://www.hiv.gov/hiv-basics/overview/data-and-trends/global-statistics) HIV.gov
[3](https://s3.amazonaws.com/academia.edu.documents/40503941/Przeg_Epidem_1-2012.pdf?AWSAccessKeyId=AKIAIWOWYYGZ2Y53UL3A&Expires=1543426649&Signature=w%2BbhtPel4KdCiU8VGFP%2BCz4nGD0%3D&response-content-disposition=inline%3B%20filename%3DDETERM_INANT_Y_PRO_ZDRO_WOTN_EJ_AKTYWNO.pdf#page=83) Olczak A., Grąbczewska E., 2012 
[4](https://ajph.aphapublications.org/doi/pdf/10.2105/AJPH.88.8.1265-a) Alemagno A. S., et al., 1998
[5](https://journals.lww.com/aidsonline/Fulltext/2014/06190/Estimating_per_act_HIV_transmission_risk___a.14.aspx) Patel P., et al., 2014
[6](http://www.ptnaids.pl/pliki/zalecenia_2016_uzupelnione.pdf#page=29) Rymer W., et al., 2016


</div>